Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer Article

Industry Collaboration International Collaboration

cited authors

  • Smit, E. F.; Socinski, M. A.; Mullaney, B. P.; Myrand, S. P.; Scagliotti, G. V.; Lorigan, P.; Reck, M.; Ciuleanu, T.; von Pawel, J.; Karaseva, N. A.; Szczesna, A.; Ohannesian, D.; Powell, E.; Hozak, R. R.; Hong, S.; Guba, S. C.; Thatcher, N.

Publication Date

  • July 1, 2012

webpage

published in

category

keywords

  • biomarkers
  • carboplatin
  • etoposide
  • pemetrexed
  • small-cell lung cancer

start page

  • 1723

end page

  • 1729

volume

  • 23

issue

  • 7